NASDAQ · Biotechnology

Arcturus Therapeutics Holdings Inc (ARCT)

$11.03 -9.22%

45 In band Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$8.70+26.78%

Company profile

Arcturus Therapeutics Holdings Inc., an RNA drug company, focuses on the treatment of liver and respiratory diseases. The company is headquartered in San Diego, California.

SectorHealthcare

IndustryBiotechnology

Market cap$342.50M

P/E ratioNone

EPS$-3.33

Beta2.483

Dividend yield0.00%

52-week high$24.17

52-week low$5.50

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 41 VRTX Vertex Pharmaceuticals Inc RSI 68 CRSP CRISPR Therapeutics AG RSI 48 IOVA Iovance Biotherapeutics Inc RSI 30 AGEN Agenus Inc RSI 47 ARTV Artiva Biotherapeutics Inc RSI 21 OCGN Ocugen Inc RSI 29 EDIT Editas Medicine Inc RSI 51 CAPR Capricor Therapeutics Inc RSI 42 ALLO Allogene Therapeutics Inc RSI 29

30 days of PRO Unlimited free, no card

RSI alerts for ARCT

An email when ARCT closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 9:46 PM EDT